Curanex Pharmaceuticals Inc Common Stock CURX · Stock Open Curanex Pharmaceuticals Inc Common Stock in new tab
Curanex Pharmaceuticals Inc Common Stock Analysis (CURX)
Is Curanex Pharmaceuticals Inc Common Stock a good investment? Curanex Pharmaceuticals Inc Common Stock (CURX) is currently trading at 4.64 USD.
Investor FAQ
Does Curanex Pharmaceuticals Inc Common Stock pay a dividend?
No, it does not currently pay a dividend.
What asset class is Curanex Pharmaceuticals Inc Common Stock?
Curanex Pharmaceuticals Inc Common Stock is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
Company Profile
Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients with inflammatory diseases. It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout. The company was formerly known as Fordman Pharma Inc. and changed its name to Curanex Pharmaceuticals Inc in November 2023. Curanex Pharmaceuticals Inc was founded in 1996 and is headquartered in Jericho, New York.
| Split Date | Split Ratio to 1 |
|---|---|
| Aug. 20, 2026 | 1:20 |
Community Discussion